<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02934802</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1420</org_study_id>
    <nct_id>NCT02934802</nct_id>
  </id_info>
  <brief_title>Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty</brief_title>
  <official_title>Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BBraun Medical SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BBraun Medical SAS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-market clinical follow-up study intends to investigate the survival rate at 5 years
      of the e.motion® PS Pro System.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate at 5 years of the e motion PS Pro</measure>
    <time_frame>the survival rate will be evaluated 6-12 weeks; 1; 2; 3; 4 and 5 years after the knee arthroplasty</time_frame>
    <description>The endpoint is the revision of at least one of the prosthesis components. If a patient withdraws from the study for any reason, counts as the end date for the survival of the implant of the last day on which the implants were well known even in place.</description>
  </primary_outcome>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Knee Arthroplasty</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Knee prothesis e motion PS Pro</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients for which a Total Knee Prosthesis with e.motion® PS Pro was decided by the surgeon
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient having signed informed consent

          -  Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided

          -  Patients willing to participate in a 5 years follow-up

        Exclusion Criteria:

          -  Active or suspected infection

          -  Tumor on the concerned knee

          -  Patient vulnerable and under legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Boillot</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe hospitalier Paris-St Joseph</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François Boillot</last_name>
    <phone>144123357</phone>
    <phone_ext>+33</phone_ext>
    <email>fboillot@hpsj.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Boubker Zniber</last_name>
    <phone>144123357</phone>
    <email>bzniber@hpsj.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe hospitalier Paris-St Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BOILLOT</last_name>
      <email>fboillot@hpsj.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2016</study_first_submitted>
  <study_first_submitted_qc>October 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

